Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00971022 · ClinicalTrials.gov registry record
Discount Generic Prescription Study
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 574
- Enrollment target
NCT00971022: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00971022 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 574 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00971022 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 574 participants
- Enrollment target
Study Summary
The goal of this study is to learn about the factors that influence people to take part in discount generic prescription programs. The primary objective of this study is to identify the factors associated with awareness and utilization of discount generic prescription programs and how two low-income populations in Houston utilize the $4 for a 30-day supply or $10 for a 90-day supply, Generic Prescriptions Program offered by Kroger, Randalls, Target, Walmart, HEB, CVS, and Walgreens.
Interventions
- BEHAVIORAL Focus Group
- BEHAVIORAL Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 574 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-05 |
What the finished NCT00971022 record still lists
NCT00971022 is an observational study that tracks outcomes without assigning an intervention. The registered 574 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Focus Group is the first listed.
NCT00971022 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00971022 about?
NCT00971022 is a clinical study titled "Discount Generic Prescription Study". The goal of this study is to learn about the factors that influence people to take part in discount generic prescription programs. The primary objective of this study is to identify the factors associated with awareness and utilization of discount generic prescription programs and how two low-incom...
What is the current status of trial NCT00971022?
This trial is currently completed. The enrollment target is 574 participants. The study started on 2009-08. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00971022?
The interventions under investigation include: Focus Group (BEHAVIORAL), Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT00971022?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07349537 · 574 participants · Phase 1
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- NCT02610439 · 575 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
- NCT05919264 · 575 participants · Phase 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- NCT06583148 · 575 participants · NA
A Smoke-Free Home Intervention in Tribal Communities
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia